Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 273  

    Article Cited by others


Improved Quality of Life in Patients Treated with Peptide Radionuclides

Traub-Weidinger T, Raderer M, Uffmann M, Angelberger P, Kurtaran A, Leimer M, Preitfellner J, Dudczak R, Virgolini I

Year : 2011| Volume: 10| Issue : 2 | Page no: 115-121

   This article has been cited by
1 Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review
Zohreh Maghsoomi,Zahra Emami,Ramin Malboosbaf,Mojtaba Malek,Mohammad E. Khamseh
BMC Cancer. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
2 Peptide receptor radionuclide therapy as a two-step strategy for initially unresectable liver disease from neuroendocrine tumors: a single-center experience
Costanza Chiapponi,Nadine Lürssen,Birgit Cremer,Roger Wahba,Uta Drebber,Michael Faust,Matthias Schmidt,Dirk L. Stippel
Endocrine. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review
D. Magalhães,I. L. Sampaio,G. Ferreira,P. Bogalho,D. Martins-Branco,R. Santos,H. Duarte
Journal of Endocrinological Investigation. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 Peptide receptor radionuclide therapy of neuroendocrine tumours
Tessa Brabander,Jaap J.M. Teunissen,Casper H.J. Van Eijck,Gaston J.H. Franssen,Richard A. Feelders,Wouter W. de Herder,Dik J. Kwekkeboom
Best Practice & Research Clinical Endocrinology & Metabolism. 2015;
[Pubmed]  [Google Scholar] [DOI]
5 Is There a Role for Peptide Receptor Radionuclide Therapy in Medullary Thyroid Cancer?
Fernanda Vaisman,Paulo Henrique Rosado de Castro,Flavia Paiva Proença Lobo Lopes,Daniel Barretto Kendler,Cencita H.N. Pessoa,Daniel Alves Bulzico,Douglas de Carvalho Leal,Bruno Vilhena,Mario Vaisman,Michel Carneiro,Rossana Corbo
Clinical Nuclear Medicine. 2015; 40(2): 123
[Pubmed]  [Google Scholar] [DOI]
6 A Bridge not too Far: Personalized Medicine with the use of Theragnostic Radiopharmaceuticals
Suresh C Srivastava
Journal of Postgraduate Medicine, Education and Research. 2013; 47(1): 31
[Pubmed]  [Google Scholar] [DOI]
7 Paving the Way to Personalized Medicine: Production of Some Promising Theragnostic Radionuclides at Brookhaven National Laboratory
Suresh C. Srivastava
Seminars in Nuclear Medicine. 2012; 42(3): 151
[Pubmed]  [Google Scholar] [DOI]


Read this article